Learn More
Medchemexpress LLC Paliperidone palmitate | 199739-10-1 | 99.9% | C39H57FN4O4 | 25 MG

Supplier: Medchemexpress LLC 25MGHYA0019A
Paliperidone palmitate is an orally effective competitive antagonist of dopamine D2 receptors and 5-hydroxytryptamine 2A (5-HT2A) receptors that can cross the blood-brain barrier. It competitively inhibits the effects of dopamine and 5-hydroxytryptamine by binding to these receptors, regulating the balance of the neurotransmitter system and thus exerting antipsychotic activity. It is primarily utilized in the research of schizophrenia.
- Competitive antagonist for dopamine D2 and 5-HT2A receptors.
- Crosses the blood-brain barrier.
- Regulates neurotransmitter system balance.
- Exerts antipsychotic activity.
- Targets dopamine and 5-HT receptors.
- Involved in GPCR/G Protein and neuronal signaling pathways.
- Used in schizophrenia research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.